ArticleThoracic cancer2025

Pathological Complete Response to a Single Dose of Pembrolizumab-Based Chemoimmunotherapy for Squamous Cell Carcinoma of the Lung: A Case Report.

Yugo Matsumura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.